Navigation Links
Nationwide Launch of Arstasis One Access Device Provides Cath Labs Across the U.S. an Alternative to Standard Arteriotomies and Vascular Closure Implants

REDWOOD CITY, Calif., Jan. 4, 2011 /PRNewswire/ -- Arstasis is pleased to announce the Arstasis One Access Device is available to physicians, nurses, patients, and cath lab technicians across the United States.  Until now, only a select number of physicians participating in Arstasis clinical trials and select pre-launch registries have been able to use the device.  As of today, the company is making the simple-to-use, disposable tool that allows physicians to perform the Arstaotomy procedure available to any qualified U.S. hospital with an accredited cardiac catheterization laboratory.

"We are delighted to begin providing U.S. cardiologists with a femoral artery access device that allows them to perform angiography without resorting to inserting a vascular closure implant into the patient," said Bruce Modesitt, CEO of Arstasis.

Along with the U.S. launch, patient enrollment is continuing in the RECITAL (A Patient Registry Evaluating Closure Following Access with the Arstasis One Access Device) study, a non-randomized, prospective, post-market registry anticipated to enroll up to 500 patients in at least seven U.S. hospitals.

Since 1959, physicians have been using the Modified Seldinger Technique to insert flexible catheters into the femoral artery of patients for the purpose of performing procedures in the patient's arterial-vascular system.  The most prevalent such procedure, diagnostic angiography, is thought to be performed more than half a million times per month worldwide.  At the end of every such case, each patient is left with a substantial hole in his/her femoral artery (upper inner thigh) which typically takes significant effort and cath lab resources to close.  With the Arstasis One Access Device, however, physicians create a shallow-angle needle pathway through the wall of the femoral artery.  At the end of the procedure, when the sheath is withdrawn, the shallow-angle pathway collapses from the normal pressure of the patient's femoral artery blood flow from below and approximately 3-4 minutes of mild, non-occlusive finger-pressure from above, resulting in a quickly sealing access site.  

Detailed information about the Arstasis One and the Arstaotomy procedure is available at


Arstasis, Inc., headquartered in Redwood City, California, is a medical device manufacturer dedicated to bringing innovative access devices to cardiologists, interventional radiologists, their staffs, and patients.  The company's first product, the Arstasis One, was cleared for U.S. commercialization by the FDA in 2010.  The device is used in the Arstaotomy™ procedure, a new way to gain access to the femoral artery that some physicians believe results in a more pleasant and efficient cath lab and post-procedure experience for clinician and patient alike.INVESTOR/MEDIA CONTACTAlexander Arrow, CFO(650)

SOURCE Arstasis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Regent Initiates Nationwide Voluntary Recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%, 50 mL Single Dose Vials Due to Particulate Matter
2. CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide
3. American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America
4. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
5. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
6. Invisible Bracelet Launches Nationwide Emergency Medical Notification Text Messaging Service
7. Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
8. Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors Offices Nationwide
9. ACTOplus met® XR (pioglitazone HCl and metformin HCl extended-release) Now Available in Pharmacies Nationwide
10. Federal Aviation Administration Selects Partners For Nationwide AED Program
11. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):